Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
March 31, 2017
Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy
Hilâl Tekatli, Shyama U Tetar, Timothy K Nguyen, et al.
Cancers
|
December 10, 2021
Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer
Isabel F Remmerts de Vries, Merle I Ronden, Idris Bahce, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2025
ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysis
Filippo Alongi, Francesco Cuccia, Rupesh Kotecha, et al.
Plos One
|
October 6, 2020
Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer
Dennie Meijer, Bernard H E Jansen, Maurits Wondergem, et al.
The Lancet. Oncology
|
December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
Daniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2016
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Andrew Warner, Max Dahele, Bo Hu, et al.
Advances in Radiation Oncology
|
April 14, 2021
An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer
Robert Rulach, David Ball, Kevin L M Chua, et al.
Virchows Archiv : an International Journal of Pathology
|
April 4, 2013
Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus
Johannes L Blaauwgeers, Ingrid Kappers, Houke M Klomp, et al.
Interactive Cardiovascular and Thoracic Surgery
|
November 4, 2021
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis
Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, et al.
Clinical Genitourinary Cancer
|
May 3, 2017
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT
Esther W Bouman-Wammes, Joyce M van Dodewaard-De Jong, Max Dahele, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Acta Oncologica (Stockholm, Sweden)
|
March 31, 2017
Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy
Hilâl Tekatli, Shyama U Tetar, Timothy K Nguyen, et al.
Cancers
|
December 10, 2021
Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer
Isabel F Remmerts de Vries, Merle I Ronden, Idris Bahce, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
December 4, 2025
ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with Stereotactic Body Radiotherapy: Delphi consensus supported by a systematic review and meta-analysis
Filippo Alongi, Francesco Cuccia, Rupesh Kotecha, et al.
Plos One
|
October 6, 2020
Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer
Dennie Meijer, Bernard H E Jansen, Maurits Wondergem, et al.
The Lancet. Oncology
|
December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report
Daniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2016
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Andrew Warner, Max Dahele, Bo Hu, et al.
Advances in Radiation Oncology
|
April 14, 2021
An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer
Robert Rulach, David Ball, Kevin L M Chua, et al.
Virchows Archiv : an International Journal of Pathology
|
April 4, 2013
Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus
Johannes L Blaauwgeers, Ingrid Kappers, Houke M Klomp, et al.
Interactive Cardiovascular and Thoracic Surgery
|
November 4, 2021
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis
Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, et al.
Clinical Genitourinary Cancer
|
May 3, 2017
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT
Esther W Bouman-Wammes, Joyce M van Dodewaard-De Jong, Max Dahele, et al.
Page
of 17